A number of US biotechs have risen 2-4 fold in last few weeks after raising capital. Let’s hope this company gets caught up in the shift in sentiment for cashed up biotechs. I might have a go at articulating specifics tomorrow if no one else does.
A very small sell side is what I see, and anyone with shares looks to be hanging on to them and not selling into this increase….which augers well…ive been in quite a few raises and to have an arbitrage like this is very uncommon. Augers well for a jump in sp next few days imo.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.050(4.17%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.15 | $146.7K | 125.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71742 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 11949 | 2 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |